Waldenström’s macroglobulinemia: Treatment methods and clonal evolution
Managing transplant ineligible AML patients
Current thought on treating chronic lymphocytic leukemia
Can ibrutinib be used as a first-line treatment in CLL?
Overview of the CLL13 trial: replacing chemotherapy with venetoclax-containing regimens
Julia von Tresckow